Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2
- PMID: 22902501
- PMCID: PMC5176099
- DOI: 10.1038/nature11333
Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2
Abstract
Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by using the pluripotency factors Oct4, Sox2, Klf4 and c-Myc (together referred to as OSKM). iPSC reprogramming erases somatic epigenetic signatures—as typified by DNA methylation or histone modification at silent pluripotency loci—and establishes alternative epigenetic marks of embryonic stem cells (ESCs). Here we describe an early and essential stage of somatic cell reprogramming, preceding the induction of transcription at endogenous pluripotency loci such as Nanog and Esrrb. By day 4 after transduction with OSKM, two epigenetic modification factors necessary for iPSC generation, namely poly(ADP-ribose) polymerase-1 (Parp1) and ten-eleven translocation-2 (Tet2), are recruited to the Nanog and Esrrb loci. These epigenetic modification factors seem to have complementary roles in the establishment of early epigenetic marks during somatic cell reprogramming: Parp1 functions in the regulation of 5-methylcytosine (5mC) modification, whereas Tet2 is essential for the early generation of 5-hydroxymethylcytosine (5hmC) by the oxidation of 5mC (refs 3,4). Although 5hmC has been proposed to serve primarily as an intermediate in 5mC demethylation to cytosine in certain contexts, our data, and also studies of Tet2-mutant human tumour cells, argue in favour of a role for 5hmC as an epigenetic mark distinct from 5mC. Consistent with this, Parp1 and Tet2 are each needed for the early establishment of histone modifications that typify an activated chromatin state at pluripotency loci, whereas Parp1 induction further promotes accessibility to the Oct4 reprogramming factor. These findings suggest that Parp1 and Tet2 contribute to an epigenetic program that directs subsequent transcriptional induction at pluripotency loci during somatic cell reprogramming.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Comment in
-
Epigenetics: Actors in the cell reprogramming drama.Nature. 2012 Aug 30;488(7413):599-600. doi: 10.1038/488599a. Nature. 2012. PMID: 22932382 No abstract available.
Similar articles
-
Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.Epigenomics. 2016 Aug;8(8):1131-49. doi: 10.2217/epi-2016-0032. Epub 2016 Jul 15. Epigenomics. 2016. PMID: 27419933 Free PMC article. Review.
-
Poly(ADP-Ribose) Polymerase 1: Cellular Pluripotency, Reprogramming, and Tumorogenesis.Int J Mol Sci. 2015 Jul 9;16(7):15531-45. doi: 10.3390/ijms160715531. Int J Mol Sci. 2015. PMID: 26184161 Free PMC article. Review.
-
Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation.Stem Cells. 2013 Nov;31(11):2364-73. doi: 10.1002/stem.1507. Stem Cells. 2013. PMID: 23939864
-
NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.Nature. 2013 Mar 21;495(7441):370-4. doi: 10.1038/nature11925. Epub 2013 Feb 10. Nature. 2013. PMID: 23395962 Free PMC article.
-
Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc.J Exp Med. 2013 Jan 14;210(1):85-98. doi: 10.1084/jem.20121044. Epub 2012 Dec 31. J Exp Med. 2013. PMID: 23277454 Free PMC article.
Cited by
-
Deciphering the TET3 interactome in primary thymic developing T cells.iScience. 2024 Apr 18;27(5):109782. doi: 10.1016/j.isci.2024.109782. eCollection 2024 May 17. iScience. 2024. PMID: 38711449 Free PMC article.
-
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.Signal Transduct Target Ther. 2024 Apr 26;9(1):112. doi: 10.1038/s41392-024-01809-0. Signal Transduct Target Ther. 2024. PMID: 38670977 Free PMC article. Review.
-
A Stem-like Patient-Derived Ovarian Cancer Model of Platinum Resistance Reveals Dissociation of Stemness and Resistance.Int J Mol Sci. 2024 Mar 29;25(7):3843. doi: 10.3390/ijms25073843. Int J Mol Sci. 2024. PMID: 38612653 Free PMC article.
-
Genome-wide ATAC-see screening identifies TFDP1 as a modulator of global chromatin accessibility.Nat Genet. 2024 Mar;56(3):473-482. doi: 10.1038/s41588-024-01658-1. Epub 2024 Feb 15. Nat Genet. 2024. PMID: 38361031
-
Metabolic control of induced pluripotency.Front Cell Dev Biol. 2024 Jan 11;11:1328522. doi: 10.3389/fcell.2023.1328522. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38274274 Free PMC article. Review.
References
-
- Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous